AstraZeneca (AZN) Short Interest Ratio & Short Volume → Bill Gates is all about this tiny $2 stock (From Timothy Sykes) (Ad) Free AZN Stock Alerts $76.90 -0.14 (-0.18%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media AstraZeneca Short Interest DataCurrent Short Volume8,530,000 sharesPrevious Short Volume8,580,000 sharesChange Vs. Previous Month-0.58%Dollar Volume Sold Short$647.26 millionShort Interest Ratio / Days to Cover1.3Last Record DateApril 30, 2024Outstanding Shares3,100,440,000 sharesPercentage of Shares Shorted0.28%Today's Trading Volume2,791,645 sharesAverage Trading Volume6,123,686 sharesToday's Volume Vs. Average46% Short Selling AstraZeneca ? Sign up to receive the latest short interest report for AstraZeneca and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAZN Short Interest Over TimeAZN Days to Cover Over TimeAZN Percentage of Float Shorted Over Time Ad Timothy SykesBill Gates is all about this tiny $2 stockWhat does Bill Gates know about this tiny company that we don’t? From the outside, it looks like a worthless $2 stock…>>Click here to discover why Bill Gates is all about this tiny $2 stock. AstraZeneca Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20248,530,000 shares $647.26 million -0.6%N/A1.3 $75.88 4/15/20248,580,000 shares $589.70 million +12.0%N/A1.4 $68.73 3/31/20247,660,000 shares $518.97 million -26.9%N/A1.2 $67.75 3/15/202410,480,000 shares $694.93 million +13.2%N/A1.7 $66.31 2/29/20249,260,000 shares $594.12 million +3.8%N/A1.5 $64.16 2/15/20248,920,000 shares $560.53 million +117.6%N/A1.4 $62.84 Get the Latest News and Ratings for AZN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AstraZeneca and its competitors with MarketBeat's FREE daily newsletter. 1/31/20244,100,000 shares $273.22 million -29.4%N/A0.7 $66.64 1/15/20245,810,000 shares $403.33 million -6.6%N/A1.1 $69.42 12/31/20236,220,000 shares $418.92 million +8.9%N/A1.1 $67.35 12/15/20235,710,000 shares $370.01 million -27.7%N/A1 $64.80 11/30/20237,900,000 shares $510.26 million -2.5%N/A1.4 $64.59 11/15/20238,100,000 shares $511.35 million -10.1%N/A1.6 $63.13 10/31/20239,010,000 shares $569.70 million +53.8%N/A1.8 $63.23 10/15/20235,860,000 shares $394.55 million -3.9%N/A1.2 $67.33 9/30/20236,100,000 shares $413.09 million -27.2%N/A1.3 $67.72 9/15/20238,380,000 shares $572.10 million +14.3%N/A1.6 $68.27 8/31/20237,330,000 shares $497.12 million +49.0%N/A1.4 $67.82 8/15/20234,920,000 shares $341.99 million -18.7%N/A0.9 $69.51 7/31/20236,050,000 shares $433.79 million -5.2%N/A1.2 $71.70 7/15/20236,380,000 shares $429.88 million -15.9%N/A1.3 $67.38 6/30/20237,590,000 shares $543.22 million +27.1%N/A1.7 $71.57 6/15/20235,970,000 shares $445.48 million +22.3%N/A1.4 $74.62 5/31/20234,880,000 shares $356.63 million +4.5%N/A1.2 $73.08 5/15/20234,670,000 shares $350.20 million -19.6%N/A1.2 $74.99 4/30/20235,810,000 shares $425.41 million +44.5%N/A1.3 $73.22 4/15/20234,020,000 shares $296.92 million +6.1%N/A0.8 $73.86 3/31/20233,790,000 shares $263.06 million +21.5%N/A0.8 $69.41 3/15/20233,120,000 shares $201.49 million -10.1%N/A0.6 $64.58 2/28/20233,470,000 shares $226.17 million +28.5%N/A0.7 $65.18 2/15/20232,700,000 shares $188.16 million +8.0%N/A0.6 $69.69 1/31/20232,500,000 shares $163.43 million -50.3%N/A0.5 $65.37 1/15/20235,030,000 shares $357.53 million +18.9%N/A1 $71.08 12/30/20224,230,000 shares $286.79 million -14.2%N/A0.8 $67.80 12/15/20224,930,000 shares $343.82 million +13.3%N/A0.9 $69.74 11/30/20224,350,000 shares $295.67 million -6.7%N/A0.7 $67.97 11/15/20224,660,000 shares $298.01 million -14.3%N/A0.7 $63.95 10/31/20225,440,000 shares $319.93 million -5.6%N/A0.8 $58.81 10/15/20225,760,000 shares $316.63 million +20.8%N/A0.9 $54.97 9/30/20224,770,000 shares $261.59 million -25.7%N/A0.7 $54.84 9/15/20226,420,000 shares $373.26 million -29.4%N/A1 $58.14get a piece of the profit from this land (Ad)This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024. AZN Short Interest - Frequently Asked Questions What is AstraZeneca's current short interest? Short interest is the volume of AstraZeneca shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 8,530,000 shares of AZN short. Learn More on AstraZeneca's current short interest. What is a good short interest ratio for AstraZeneca? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AZN shares currently have a short interest ratio of 1.0. Learn More on AstraZeneca's short interest ratio. Which institutional investors are shorting AstraZeneca? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AstraZeneca: Walleye Trading LLC, Twin Tree Management LP, SAL Trading LLC, Concourse Financial Group Securities Inc., Simplex Trading LLC, Raymond James & Associates, IMC Chicago LLC, and Readystate Asset Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is AstraZeneca's short interest increasing or decreasing? AstraZeneca saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 8,530,000 shares, a decrease of 0.6% from the previous total of 8,580,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does AstraZeneca's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to AstraZeneca: Novartis AG (0.22%), AbbVie Inc. (0.82%), Abbott Laboratories (0.84%), Pfizer Inc. (1.10%), Merck & Co., Inc. (0.74%), Sanofi (0.22%), Johnson & Johnson (0.74%), Vertex Pharmaceuticals Incorporated (1.50%), Regeneron Pharmaceuticals, Inc. (1.42%), GSK plc (0.44%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short AstraZeneca stock? Short selling AZN is an investing strategy that aims to generate trading profit from AstraZeneca as its price is falling. AZN shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against AstraZeneca? A short squeeze for AstraZeneca occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AZN, which in turn drives the price of the stock up even further. How often is AstraZeneca's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AZN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: NVS Short Squeeze ABBV Short Squeeze ABT Short Squeeze PFE Short Squeeze MRK Short Squeeze SNY Short Squeeze JNJ Short Squeeze VRTX Short Squeeze REGN Short Squeeze GSK Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AZN) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBill Gates is all about this tiny $2 stockTimothy SykesCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressMan who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.”InvestorPlaceForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the Markets[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsShocking $16T Elon Musk Crypto LeakCrypto 101 Media